tanshinone has been researched along with Stroke in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, J; Callaway, TR; Duberstein, KJ; Fagan, MM; Jeon, JH; Kaiser, EE; Kinder, HA; Kumar, A; Lourenco, JM; Park, HJ; Platt, SR; Rothrock, MJ; Scheulin, KM; Shin, SK; Sneed, SE; Waters, ES; West, FD; Xie, J; Yang, X | 1 |
| Bao, XQ; Li, DC; Sun, H; Zhang, D | 1 |
| Cui, L; Du, W; Li, M; Liu, L; Wang, L; Wang, S; Yang, R; Zhang, X | 1 |
| Bi, XY; Chen, L; Deng, BQ; Ding, SJ; Qiu, YQ; Zhu, LX | 1 |
| Chow, MS; Zhou, L; Zuo, Z | 1 |
| Chan, E; Chen, X; Chowbay, B; Duan, W; Li, CG; Liang, J; Lin, SG; Sheu, FS; Wen, JY; Yu, XQ; Yu, XY; Zhou, SF; Zhou, ZW | 1 |
2 review(s) available for tanshinone and Stroke
| Article | Year |
|---|---|
[Research progress in the study of protective effect of tanshinone IIA on cerebral ischemic stroke].
Topics: Abietanes; Antioxidants; Apoptosis; Drugs, Chinese Herbal; Humans; Salvia miltiorrhiza; Stroke | 2015 |
Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use.
Topics: Abietanes; Angina Pectoris; Animals; Benzofurans; Drugs, Chinese Herbal; Fibrinolytic Agents; Herb-Drug Interactions; Humans; Hyperlipidemias; Lactates; Phenanthrenes; Phenanthrolines; Plant Extracts; Randomized Controlled Trials as Topic; Salvia miltiorrhiza; Stroke | 2005 |
1 trial(s) available for tanshinone and Stroke
| Article | Year |
|---|---|
[Flavonoids of puerarin versus tanshinone II A for ischemic stroke: a randomized controlled trial].
Topics: Abietanes; Aged; Aged, 80 and over; Brain Ischemia; Brain-Derived Neurotrophic Factor; Female; Humans; Interleukin-6; Isoflavones; L-Lactate Dehydrogenase; Male; Middle Aged; Phytotherapy; Stroke; Treatment Outcome; Vasodilator Agents | 2011 |
3 other study(ies) available for tanshinone and Stroke
| Article | Year |
|---|---|
Tanshinone IIA-loaded nanoparticles and neural stem cell combination therapy improves gut homeostasis and recovery in a pig ischemic stroke model.
Topics: Animals; Fatty Acids, Volatile; Inflammation; Ischemic Stroke; Male; Nanoparticles; Neural Stem Cells; Stroke; Swine; Tumor Necrosis Factor-alpha | 2023 |
The neuroprotective effects of Tanshinone IIA are associated with induced nuclear translocation of TORC1 and upregulated expression of TORC1, pCREB and BDNF in the acute stage of ischemic stroke.
Topics: Abietanes; Active Transport, Cell Nucleus; Animals; Brain Ischemia; Brain-Derived Neurotrophic Factor; Cyclic AMP Response Element-Binding Protein; Drugs, Chinese Herbal; Humans; Male; Neuroprotective Agents; Neuropsychological Tests; Phenanthrenes; Rats; Rats, Sprague-Dawley; Stroke; Transcription Factors; Up-Regulation | 2010 |
Tanshinone IIB, a primary active constituent from Salvia miltiorrhza, exhibits neuro-protective activity in experimentally stroked rats.
Topics: Abietanes; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Brain; Brain Infarction; Disease Models, Animal; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Infarction, Middle Cerebral Artery; Injections, Intraperitoneal; Male; Nerve Degeneration; Neurons; Neuroprotective Agents; Phenanthrenes; Plant Extracts; Rats; Rats, Sprague-Dawley; Salvia miltiorrhiza; Stroke; Treatment Outcome | 2007 |